Laser and steroid mouthwash aim to tame painful mouth sores in autoimmune disease
NCT ID NCT07641725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a steroid mouthwash (clobetasol propionate 0.05%) and low-level laser therapy, alone or together, can heal painful mouth sores in people with pemphigus vulgaris—a chronic autoimmune disease that causes blisters on skin and mucous membranes. Thirty participants with active oral lesions will be randomly assigned to one of three groups: mouthwash only, laser only, or both. The goal is to see if these topical treatments can reduce lesion severity and pain, potentially allowing patients to lower their systemic steroid doses and avoid long-term side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clobetasol propionate 0.05% mouthwash and photobiomodulation (low-level laser therapy)
- What this could lead to
- If effective, these topical treatments could speed healing of oral lesions and allow patients to lower their steroid doses, reducing long-term side effects.
- What could go wrong
- This is a small, early-stage study with only 30 participants, so results may not apply broadly. The treatments are supportive, not a replacement for systemic therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL LESIONS IN PATIENTS WITH PEMPHIGUS VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Oral Medicine, Faculty of Dental medicine
RECRUITINGDamascus, Syria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at blistering skin disease
- Can an extra shot boost COVID protection in autoimmune patients?
- Scientists probe hidden clot risks in autoimmune skin disorders
- Researchers track blistering skin disease to pave way for better treatments
- Dose debate: which rituximab regimen works best for rare blistering disease?
- Insulin ointment shows promise for speeding up wound healing in rare blistering disease